Abstract
Objectives The aim of this study was to describe and analyze the generation of priority areas for Covid-19 testing combining participatory surveillance and traditional surveillance.
Design The study is a descriptive transversal, where was performed in the city of Caruaru, Pernambuco state, within the period of 20/02/2020 to 05/05/2020. It was considered all official reports for flu syndromes notified by municipality health department and the data collected through the participatory surveillance platform Brasil Sem Corona.
Methods To verify a correlation between Participatory Surveillance (PS) and Traditional Surveillance (TS), it was carried out a linear regression.
Results The PS has showed in Caruaru 861 active users, presenting an average of 1.2 report per user per week. It was started in March 20th and is officially used by the local health authority in order to improve the quality of information from traditional surveillance system. Regarding to the respiratory syndrome cases from TS, it was found out 1,588 individuals that were positive for this clinical outcome. The spatial scanning analysis has detected 18 clusters and 6 of them have presented statistical significance (p-value < 0.1). Clusters 3 and 4 presented an overlapping and this area was chosen by local authority to deploy the Covid-19 serology, where 50 individuals were tested. From there, 32% (n=16) presented reagent results for antibodies related to Covid-19.
Conclusion The use of alternative methods as participatory surveillance showed a relevant role taking advantage on the insertion at community levels to complement traditional surveillance system.
Competing Interest Statement
In order to make clear the commercial affiliation of some authors in this paper, we would like to declare that OBLN and JYL worked in the project as key-professionals in the development and implementation of platform as well as the conceptualization, data analysis and writing of this study. Beyond that Epitrack and Colab provided support in the form of salaries for authors [OBLN and JYL].
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study had exemption from oversight body (Caruaru Health Department and Brasil Sem Corona scientific committee) since it was used only public domain data available from secondary sources.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data from Brasil Sem Corona can be obtained by formal requisition by www.brasilsemcorona.com.br The data from respiratory syndrome was collected by the official disease surveillance bulletin provided by Caruaru Health Department, where is public available.